Cambridge Healthtech Institute's Tenth Annual
Engineering Genes and Hosts
( 基因与宿主的改变 )
Exploring Strategies in Systems Engineering and Synthetic Biology
2018年1月8日 - 9日
The mandate of "faster, better, less expensive" resonates with recombinant protein expression and production researchers. Thus, protein expression scientists are exploring new engineering tools including synthetic biology and systems engineering. However, many variables still must be considered during the engineering process, including verification and sequence analysis of the gene or protein of interest, codon optimization, vector construction and clone/host selection. Ultimately, as with any new system, these tools must be weighed against traditional expression and production strategies to achieve the desired quantity and quality.
Cambridge Healthtech Institute's Tenth Annual Engineering Genes and Hosts conference continues the tradition of applying effective engineering strategies for protein expression and production research leading to functional protein products. Learn from seasoned, savvy researchers as they share their real-world experiences, applications and results.
CRISPR-Cas Tools for Host Cell Improvement in the Baculovirus-Insect Cell System
Donald Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming
New Strategies of CRISPR/Cas9-Based High-Throughput Functional Genomic Screening
Dongxin Zhao, Ph.D., Postdoctoral Fellow, Prashant Mali Lab, Department of Bioengineering, University of California, San Diego
Codon and Codon Context Optimization in Synthetic Gene and Gene Library Design
Dimitris Papamichail, Ph.D., Assistant Professor, Computer Science, The College of New Jersey
Establishing Protein Production without Reinventing the Wheel: ProteinData.Cloud
Peter Nollert, Ph.D., Business Director, Research and Development, Bio Data Bridges
Mammalian Display: Antibody Discovery, Affinity Maturation and Developability Screening in IgG Format
Mike Dyson, Ph.D., CTO, IONTAS Ltd.
Engineering Cell Factories for Protein Production
Bjorn Voldborg, Director, CHO Cell Line Development, NNF-Center for Biosustainability, Technical University of Denmark